Urgent and competing demands are challenging the clinical development efforts of today’s biopharmaceutical companies. Pressures to enhance innovation, feed pipelines, and improve efficiency and quality, all while lowering costs in an evolving regulatory environment are more acute than ever before.
An immediate response to these challenges has been for biopharmaceutical companies to cut costs in order to improve profitability primarily through mergers and acquisitions, reductions in workforces…
A Case Study: Applying the Principles
Brenda Hoeper, Senior VP, Strategic Resourcing, inVentiv Health Clinical. inVentiv Health Clinical, formerly PharmaNet/i3, is a provider of global drug development services to pharmaceutical, biotechnology, generic drug, and medical device companies. With 7,000 employees operating in more than 70 countries, inVentiv Health Clinical offers therapeutically specialized capabilities for all phases of clinical development, bioanalytical services, and strategic resourcing from a single clinical professional to an entire functional team. For more information, visit inventivhealthclinical.com.